The NIFTY opened at 18319.10 with a gap down of 95 points. The index continued moving downwards but found support around 18270 and bounced up sharply. Prices quickly erased all the losses and went above 18400 but found strong resistance there and turned down. A decline again recorded its intraday low at 18255.15 & finally closed at 18269 near its daily low with a loss of 145 points or 0.79% down. All the sectors underperformed today and ended with a loss. The short-term trend is sideways. We have a support level of around 18000 in the NIFTY index. A close below this level will indicate avoiding buying. A close below this support will suggest us taking short trade in the index. A likely resistance should now emerge around the 18500 mark. We expect consolidation here since the index has seen a sharp upside move in the past few weeks. We should now avoid trading the index and wait for an adequate setup to emerge.


The BANK NIFTY opened at 43261.75 with a gap down of 236 points. In its initial trade, the index recorded its intraday low at 43080 and started moving higher. A sharp rally brought prices above 43400 and then the index turned down towards 43000. Prices have again moved up, going above 43200. The index finally closed at 43219 with a loss of 278 points. PSU BANKS & PVT BANKS both underperformed today and ended with a loss of 2.92% & 0.61% respectively. Within the index, in terms of points, HDFC BANK contributed the highest on the upside while PNB contributed the lowest. It was a volatile day today in the index where prices have seen moves in both directions, the index has ended near its daily low. The short-term trend is sideways and prices are now heading towards psychological support at the 43000 mark. Resistance is visible at around 43600. We should now wait for some kind of consolidation for fresh trading opportunities.


INDIAN HOTEL 327.15 SELL The stock has given a breakdown on the intraday as well as the daily chart. The stock can be sold at 327.15 with a stop loss of 329.65 and a target of 323.30.
SUN PHARMA 993.65 SELL The stock has given a breakdown on the intraday as well as the daily chart. The stock can be sold below 987.55 with a stop loss of 998.15 and a target of 966.15.


Stock Name Strike Price Buy/Sell CMP Initiation Stop Loss Target Remarks

Long Buildup Short Buildup
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
BALRAMCHIN.2212Dec 395.85 2.88 6.66 9044800 IRCTC.22.12 Dec 673.65 -8.48 11.27 16548000
GODREJCP.22.12 Dec 899.6 0.69 0.56 4822000 BEL.22.12 Dec 99.7 -5.94 2.71 106572900
TVSMOTOR.22.12 Dec 1037.9 0.4 0.05 7565600 ABB.22.12 Dec 2847.9 -5.93 1.1 1998000
METROPOLIS.22.12 Dec 1297.05 -5.9 20.35 1515000
CANBK.22.12 Dec 311.8 -5.36 9.64 46539900
                                                                        Short Covering                                                                       Long Unwinding
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
PEL.22.12 Dec 894.45 2.03 -6.66 6105550 POLYCAB.22.12 Dec 2753.85 -8.32 -14.54 913200
IBULHSGFIN.22.12 Dec 147.4 0.99 -11.22 35876000 INDIACEM.22.12 Dec 230.4 -7.28 -1.49 15744100
GAIL.22.12 Dec 97.25 0.52 -8.13 54158850 CUB.22.12 Dec 191.15 -6.51 -4.54 9775000
COLPAL.22.12 Dec 1585.35 0.42 -9.07 2497950 BHEL.22.12 Dec 81.1 -6.13 -7.04 85501500
ABBOTINDIA.22.12 Dec 20737.3 0.39 -8.06 41960 HINDCOPPER.22.12 Dec 111.35 -6.11 -0.67 19642400
Stocks Price %Chg Total Qty Delivery Del % % Change
Sectors Price Change % Quantity
Mah & Mah Ltd. 1251.6 -2.75 2136354 1270190 76.75 Nifty50 18269 -0.79 35779816
Infosys Limited 1522.2 -1.19 9630453 5420140 69.59 Niftybank 43219.5 -0.64 15133333
Bharti Airtel Limited 822.75 -0.44 4309644 2913148 68.41 Nifty it 28702.2 -1.33 1581334
Hdfc Ltd. 2667.45 -0.18 3188884 2189015 68.19 India Vix 14.07 2.48 467548317
Axis Bank Limited 935.1 -0.33 6926928 4016160 67.91 Nifty Fmcg 45320.75 -0.49 451493
Jublfood 520.2 -0.7 1398385 512891 67.48 Nifty Pharma 12636.2 -1.4 51571337
United Spirits Limited 903.6 -3.77 1324668 598631 66.25 Nifty Realty 439.8 -1.51 1479641582
Reliance Industries Ltd 2565.6 -0.49 7308934 3995069 65.59 Nifty Auto 12775.25 -1.07 51103301
Ntpc Limited 169.8 -1.34 9433166 5419455 65.47 Nifty Metal 6657.7 -0.76 98178224
Hindustan Unilever Ltd 2671.3 0.3 1793864 1188892 65.42 Nifty Financial Services 19111.95 -0.54 3435822


   Domestic                                                                                                                                                  International
INR: Federal Fiscal Deficit (Nov) on 30th December, 2022

INR: Infrastructure Output (YoY) (Nov) on 30th December, 2022

 USD: Building Permits (Nov) on 20th  December, 2022

USD: GDP (QoQ) (Q3) on 22nd  December, 2022


  • Benchmark indices ended lower for the second consecutive session on December 16.At Close, the Sensex was down 461.22 points or 0.75% at 61,337.81, and the Nifty was down 145.90 points or 0.79% at 18,269. About 1391 shares have advanced, 2026 shares declined, and 125 shares are unchanged.

  • Indraprastha Gas Ltd (IGL) has hiked CNG prices across India, including Delhi-NCR, with effect from December 17.

  • Canada Pension Plan Investment Board (CPP Investments) announced on December 17 that it has agreed to sell its 49 percent stake in L&T Infrastructure Development Projects Limited (L&T IDPL).Larsen & Toubro (L&T), which holds the remaining 51 percent stake in L&T IDPL, will also be selling its stake.

  • Temasek likely to buy TPG’s nearly 21% stake in Manipal Health

  • The deal would value the hospital chain above $4 billion. For TPG, which first acquired a 24.75 percent stake for Rs 900 crore in Manipal Health in 2015, this deal will generate multi-fold returns

Source: Economic Times, Indian Express, Business Today, Livemint, Business Standard, Bloomberg Quint



Company Name Purpose Meeting Date Company Name Purpose Meeting Date
ACROW General 19-Dec-22 RKDAGRRTL Issue Of Warrants 21-Dec-22
FRUTION General 19-Dec-22 SAGCEM Amalgamation 21-Dec-22
GAL General 19-Dec-22 SALAUTO General 21-Dec-22
GENESYS Amalgamation 19-Dec-22 SANKHYAIN Preferential Issue of shares;Reduction of Capital;Scheme of Arrangement 21-Dec-22
GOODLUCK Preferential Issue of shares;Issue Of Warrants 19-Dec-22 VIVOBIOT Preferential Issue of shares;Issue Of Warrants 21-Dec-22
GUJSTATFIN Quarterly Results 19-Dec-22 ZODIACLOTH Preferential Issue of shares 21-Dec-22
HGS Buy Back of Shares 19-Dec-22 FILME General 22-Dec-22
SBC Buy Back of Shares 19-Dec-22 JAYANT General 22-Dec-22
SOURCENTRL General 19-Dec-22 SARTHAKIND General 22-Dec-22
TRU Preferential Issue of shares;Issue Of Warrants 19-Dec-22 SUPREMEINF Quarterly Results;General 22-Dec-22
VISAGAR Right Issue of Equity Shares 19-Dec-22 TAINWALCHM General 22-Dec-22
ADROITINFO Employees Stock Option Plan;General 20-Dec-22 HITTCO General 23-Dec-22
ASHIMASYN General 20-Dec-22 OISL Audited Results 23-Dec-22
IKAB General 20-Dec-22 PARMCOS-B General 23-Dec-22
INLCM General 20-Dec-22 TRIVENIGQ General 23-Dec-22
JYOTIRES General 20-Dec-22 SRTRANSFIN Interim Dividend;General 24-Dec-22
LESHAIND General 20-Dec-22 KUNSTOFF General 26-Dec-22
RAJPALAYAM Right Issue of Equity Shares 20-Dec-22 ARCFIN Right Issue of Equity Shares;Rights Issue 27-Dec-22
SCTL Preferential Issue of shares 20-Dec-22 ALEXANDER Preferential Issue of shares 28-Dec-22
SMLT Interim Dividend;General 20-Dec-22 SANGHIIND General 02-Jan-23
BHATIA General 21-Dec-22 KARNAVATI Stock  Split 03-Jan-23
BRFL Quarterly Results 21-Dec-22 HCLTECH Interim Dividend;Quarterly Results 12-Jan-23
GICRE General 21-Dec-22 INFY* Quarterly Results 12-Jan-23
INDLMETER Quarterly Results 21-Dec-22 HDFCBANK Quarterly Results 14-Jan-23
MTARTECH General 21-Dec-22 KSOLVES Quarterly Results 15-Jan-23
PIFL General 21-Dec-22 COFORGE Interim Dividend;Quarterly Results 20-Jan-23
RHETAN Increase in Authorised Capital;Bonus issue;Stock  Split;General 21-Dec-22 ABB A.G.M.;Audited Results;Quarterly Results;Dividend 10-Feb-23
Company Name Ex-Date Purpose Company Name Ex-Date Purpose
SHAWGELTIN 19-Dec-22 Special Dividend – Rs. – 100.0000 TRITURBINE 22-Dec-22 Buy Back of Shares
PRATIK 20-Dec-22 Reduction of Capital TRIVENI 22-Dec-22 Buy Back of Shares
SANKHYAIN 20-Dec-22 Reduction of Capital ZIMLAB 22-Dec-22 Bonus issue 2:1
SANKHYAIN 20-Dec-22 Resolution Plan -Suspension LAFFANSQ 23-Dec-22 E.G.M.
SARTHAKIND 20-Dec-22 Bonus issue 1:3 NATHIND 23-Dec-22 E.G.M.
SFL 21-Dec-22 Bonus issue 1:1 SAGARPROD 23-Dec-22 E.G.M.
KAMAHOLD 22-Dec-22 Buy Back of Shares ECLERX 26-Dec-22 Buy Back of Shares
ORCHIDPHAR 22-Dec-22 E.G.M. SECURCRED 26-Dec-22 Bonus issue 3:1
PRECWIRE 22-Dec-22 Bonus issue 1:2 FILATEX 27-Dec-22 Stock  Split From Rs.2/- to Rs.1/-
QUINT 22-Dec-22 Right Issue of Equity Shares ADVAIT 28-Dec-22 Bonus issue 1:1

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited,
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting, or emailing with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website:
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL